Skip to main content

Written question asked by Robert Syms (Conservative) on Monday, 2 December 2002, in the House of Commons. It was due for an answer on Wednesday, 11 December 2002. It was answered by Baroness Smith of Malvern (Labour) on Wednesday, 11 December 2002 on behalf of the Department of Health.


Dept of Health

Question
To ask the Secretary of State for Health, if he will make a statement on the availability to NHS patients of the drug Ebixa for the treatment of Alzheimer's disease; when the National Institute of Clinical Excellence will issue guidance on the use of Ebixa for the NHS in England and Wales; and what interim measures have been put in place to ensure that the drug Ebixa will be available to NHS patients pending the outcome of the NICE appraisal; what estimate his Department has made of the cost per annum of providing the drug Ebixa to NHS patients suffering from late stage Alzheimer's disease in (a) Dorset and (b) England; what provisions his Department has put in place to ensure that NHS patients in Dorset who suffer from Alzheimer's disease and who would benefit from the drug Ebixa are able to receive that drug.

Secondary information

Type
Written question
Reference
396 c393W; 85467;85470;85468
Session
2002-03
Subjects
Alzheimer's disease Drugs
Link
View this Written question on www.publications.parliament.uk